Advancing Breast Cancer Precision Medicine
We bridge the gap between complex molecular biology and clinical utility.
Our research programs are unified by a single focus: understanding breast cancer biology across the disease continuum. From identifying the earliest tissue changes to decoding the intrinsic factors governing therapeutic response, we design the tools that define the future of oncology.
Core Pillars of the Heng Lab
Multimodal Research: We integrate wet-lab, computational biology, and translational strategies to address clinically important problems that cannot be solved within a single field.
A Global Network: We partner with world-class physicians and scientists across Harvard, USA, and international institutions.
Equitable Medicine: Pioneering critical research in transgender cancer to ensure precision medicine serves all populations.